What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to provide notice to investors about upcoming meetings between Anthem's management and securities analysts/investors, during which the company is expected to confirm its ability to meet prior earnings guidance.

What earnings expectations is Anthem referring to?

Anthem is referring to the earnings expectations that were communicated to the public via a press release and conference call on January 29, 2004. Details of these expectations can be found in the referenced press release and conference call transcript.

What are the key risks mentioned in the filing that could affect future performance?

The filing reiterates various risks, including trends in healthcare costs and utilization, the ability to secure premium rate increases, competitor pricing, increased government regulation, significant competitor actions, the introduction of new drugs and technology, financial strength rating downgrades, litigation, provider contracting, the successful integration and expected synergies of the merger with WellPoint Health Networks Inc., potential public health epidemics, and general economic downturns.

Is the information in this filing considered 'filed' for legal purposes?

No, the filing explicitly states that the information furnished in this report shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, and will not be incorporated by reference into any filings under the Securities Act of 1933.

ELV 8-K SEC Disclosure

Summary

This 8-K filing from Anthem, Inc. (now Elevance Health, Inc.) on March 1, 2004, primarily serves to inform investors about upcoming meetings with securities analysts and investors scheduled for the weeks of March 1 and March 8, 2004. During these meetings, the company's management is expected to confirm its ability to meet previously issued earnings expectations. These expectations were initially communicated in a press release and conference call on January 29, 2004. The filing also includes a standard disclaimer regarding forward-looking statements and reiterates the risks and uncertainties that could impact future performance, including those related to the anticipated merger with WellPoint Health Networks Inc.

Key Highlights

1Anthem, Inc. is scheduled to meet with securities analysts and investors during the weeks of March 1 and March 8, 2004.
2Company officers are expected to reaffirm Anthem's ability to meet earnings expectations previously provided on January 29, 2004.
3This filing serves as a disclosure under Regulation FD.
4The company references a January 29, 2004 press release and a January 30, 2004 conference call transcript for prior financial guidance.
5The filing includes standard cautionary language regarding forward-looking statements and associated risks and uncertainties.
6Key risks highlighted include those related to healthcare costs, premium rate increases, government regulation, competitor actions, and the potential impact of the proposed merger with WellPoint Health Networks Inc.

Elevance Health, Inc. 8-K Report (Mar 1, 2004)

Summary

Key Highlights

Frequently Asked Questions